SPR Therapeutics is a medical device company, which engages in developing and commercializing interventional pain management therapies. The Company develops Smartpatch, a percutaneous peripheral nerve stimulation (PNS) system for post-surgical pain following surgeries, such as knee replacement, thoracotomy, and rotator cuff repair; neuropathic pain, including pain following nerve injury, as well as nerve surgery, such as phantom limb pain; and musculoskeletal pains, such as shoulder and knee pains. It offers Smartpatch short-term therapy for sustained relief; Micropulse long term therapy through implantable PNS system; and Smartpatch MicroLead, which includes a coiled wire construction that fosters rapid tissue ingrowth.
|Employees (est.) (Nov 2020)||71||(+6%)|
SPR Therapeutics total Funding
SPR Therapeutics latest funding size
Time since last funding
|3 years ago|
SPR Therapeutics investors
|JumpStart Inc., Frontcourt Ventures|
When was SPR Therapeutics founded?
SPR Therapeutics was founded in 2009.
Who are SPR Therapeutics key executives?
SPR Therapeutics's key executives are Maria E. Bennett, David Youngberg and Mark Stultz.
How many employees does SPR Therapeutics have?
SPR Therapeutics has 71 employees.
Who are SPR Therapeutics competitors?
Competitors of SPR Therapeutics include LimFlow, Acelity and Articulinx.
Where is SPR Therapeutics headquarters?
SPR Therapeutics headquarters is located at 22901 Millcreek Blvd #110, Beachwood.
Where are SPR Therapeutics offices?
SPR Therapeutics has an office in Beachwood.
How many offices does SPR Therapeutics have?
SPR Therapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies